Zebeta®
Bisoprolol is a highly selective beta-1 blocker for hypertension and heart failure. Demonstrates the highest beta-1 selectivity among beta-blockers.
| Dosage Form | Oral Tablet |
| Strength | 1.25 mg, 2.5 mg, 5 mg, 10 mg |
| Storage | Store at 20–25°C. |
| Category | Cardiovascular |
| Availability | Available for Transfer |
Hypertension; chronic heart failure (NYHA II-IV, with ACE inhibitor and diuretic).
Highly selective beta-1 adrenergic antagonist that decreases cardiac output, reduces renin release, and decreases sympathetic outflow from the CNS.
Each Burrard Pharmaceuticals technology transfer package for Bisoprolol includes comprehensive documentation and support:
Complete formulation with manufacturing parameters, excipient specifications, and process controls.
Validated methods for assay, impurities, dissolution, and stability-indicating analysis.
Market-ready regulatory dossier sections for a named territory, scoped per programme.
ICH-compliant stability studies (accelerated and long-term) with detailed protocols.
Scale-up procedures, batch records, equipment specifications, and in-process controls.
Direct advisory access to formulation scientists and regulatory specialists throughout transfer.
Scope and timing for the complete know-how package are confirmed in writing after a confidentiality agreement. Book a consultation to discuss your specific requirements.